Greenfield project is expected to be fully operational by end of 2030 Integrated refining and petrochemical project aims to maximize chemical output Complex expected to supply around five million ...

Premium Resources Ltd. (TSXV: PNRL) ("PRL" or the "Company") is pleased to announce that the Company has changed its name from "Premium Nickel ...

In collaboration with Toronto Metropolitan University, the Government of Canada will invest $3.9M CAD in the Malaysia ...

As COP29 kicked off under the theme "In Solidarity for a Green World", the event brought together global leaders, policymakers, and industry stakeholders ...

Third Quarter Revenues of RMB 1,023.9 million, an increase of 10.5% year-over-year -- Third Quarter Net Loss of RMB 40.9 million, compared to Net Loss of RMB 79.4 million in the same period of last ...

EXOSENS ENTERS INTO EXCLUSIVE NEGOTIATIONS TO ACQUIRE NOXANT, SPECIALIZED IN HIGH PERFORMANCE COOLED INFRARED CAMERAS PRESS RELEASEMÉRIGNAC - PALAISEAU, FRANCE - NOVEMBER, 18th 2024 Exosens announces ...

Bíldudalur, 18 November 2024Icelandic Salmon is the parent company of Arnarlax and its subsidiaries, which are involved in salmon farming and processing in Iceland. The companies are collectively refe ...

Operational EBIT for Norway was NOK 1,082 million in the third quarter of 2024. The harvest volume was 56,400 tonnes, and operational EBIT per kg was NOK 19.2.Operational EBIT for the group was NOK 1 ...

EZCORP, Inc. (NASDAQ: EZPW), a leading provider of pawn transactions in the United States and Latin America, today announced results for its fourth quarter ...

Presented data at EADV supporting potential of ESK-001 as differentiated oral treatment in immune-mediated diseases through maximal TYK2 inhibition - - Continued to advance three clinical programs ...

Anzeige / WerbungDer Analystenkommentar von Auctus Advisors LLP, veröffentlicht am 6. November 2024, hebt die Fortschritte ...

BASEL (dpa-AFX) - Ratio Therapeutics Inc. Monday announced partnership with Novartis Pharma AG, a unit of Novartis AG (NVS) to develop a radiotherapeutic candidate for cancer. As per the deal ...